USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 11, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 11, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 7, 2008 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 15, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 25, 2008 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jun 10, 2008 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 10, 2008 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 10, 2008 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 10, 2008 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 10, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 10, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 10, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jun 5, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 4, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 4, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 28, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 28, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 28, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 20, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 14, 2008 | MPMK | O | NOTICE OF PSEUDO MARK MAILED | Loading... |
| Feb 13, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing online non-downloadable software for use in the management of an online browser based, searchable database to aid the pharmaceutical, medical or surgical device and biotechnology industries, as well as medical practice groups/clinics, hospitals, healthcare regulatory bodies, contract research organizations, and other associated healthcare organizations in identifying adverse events, risk assessment and risk predictability during the drug, medical or surgical device and non-drug clinical development and post-marketing surveillance processes by identifying and quantifying patient-specific and non-patient specific adverse events and determining the degree of seriousness, degree of risk and cost-effectiveness of various therapeutic strategies
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
GATE PASS
Classification
International Classes
042